<-- Apollo GTM --> <-- End Apollo GTM-->

Pfizer's Sickle Cell Strategy Stumbles: Inclacumab Fails Phase III Oxbryta Withdrawn

Clinical TrialsFDATherapuetics

Aug 27

Written By Corey Hubbard

GlassBury Cares Podcast

Episode #32

PfizerSickle CellResearchDr. Cece Calhoun

Unlock the Alzheimer's Enigma: Science, Struggle, and the Art of Connection

Lantern Pharma Completes Japan Enrollment for Phase II LP-300 NSCLC Trial Ahead of Schedule